JPMorgan initiates Arcus Biosciences stock at Overweight, $41 target By Investing.com - Investing.com India

Source: Investing.com India · 2026-10-14T07:44:49+00:00

JPMorgan initiates Arcus Biosciences stock at Overweight, $41 target By Investing.com Investing.com India

BestAIBroker analysis

Finance-aware sentiment: positive (+0.60 on a -1 to +1 scale).
Event classification: OTHER.
Market importance score: 31/100, weighting entity relevance, source credibility, multi-outlet coverage and recency.
Symbols referenced: RCUS, JPLD.